CVS Health (CVS) Q1 FY2026 earnings: revenue $100.4 billion, up 6.2% on the year
CVS Health Corp. (CVS) reported revenue of $100.4 billion for Q1 FY2026, the quarter ended 31 March 2026, up 6.2% on the same quarter a year earlier. Net income was $2.9 billion, up 65.4% on the year, and diluted earnings per share $2.30. The figures are the company's own, from the 10-Q it filed with the SEC on 6 May 2026.
Revenue
$100.4 billion
+6.2% on the year · -5.0% on the quarter
Q2 FY2024Q1 FY2026
Operating margin
4.7%
3.6% a year earlier
Q2 FY2024Q1 FY2026
Net income
$2.9 billion
+65.4% on the year · 0.0% on the quarter
Q2 FY2024Q1 FY2026
Diluted EPS
$2.30
+63.1% on the year · 0.0% on the quarter
Q2 FY2024Q1 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
What management said
Guidance figures: 5 raised, 2 kept.
Revenue rose 6.2% across segments: Total revenues were $100.4 billion, up from $94.6 billion, with growth in every operating segment.
Adjusted EPS rose to $2.57: Adjusted EPS was $2.57 against $2.25; GAAP diluted EPS was $2.30 against $1.41. Management attributed the adjusted increase mainly to Health Care Benefits.
Segment adjusted operating income up 52.6%: Adjusted operating income was $3.04 billion, an 8.5% margin against 5.7%. The gain reflected Government improvement and no repeat of last year's $448 million individual exchange premium deficiency reserve.
$ million except per share. Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q1 FY2026
Q4 FY2025
Q1 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
4,249
3,390
4,556
+25.3%
-6.7%
Capital expenditure
849
784
743
+8.3%
+14.3%
Free cash flow
3,400
2,606
3,813
+30.5%
-10.8%
Free cash flow margin
3.4%
2.5%
4.0%
Cash from investing
-874
-1,998
-762
Cash from financing
-2,318
-2,032
-2,332
Depreciation and amortisation
1,115
1,147
1,154
-2.8%
-3.4%
Share-based compensation
266
135
126
+97.0%
+111.1%
Buybacks
n/a
0.0
0.0
Dividends paid
847
845
840
+0.2%
+0.8%
Dividend per share
$0.67
$0.67
$0.67
0.0%
0.0%
Diluted shares, weighted
1,279m
1,277m
1,264m
+0.2%
+1.2%
Shares outstanding at period end
1,273m
1,271m
1,262m
+0.2%
+0.9%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q1 FY2026
Q4 FY2025
Q1 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
77,456
75,214
76,929
+3.0%
+0.7%
Non-controlling interest
181
168
181
+7.7%
0.0%
Debt
63,111
64,570
64,710
-2.3%
-2.5%
Operating lease liabilities
13,330
13,643
14,594
-2.3%
-8.7%
Finance lease liabilities
n/a
1,265
n/a
Other liabilities
98,896
98,678
99,171
+0.2%
-0.3%
Total liabilities and equity
252,974
253,538
255,585
-0.2%
-1.0%
Goodwill
85,478
85,478
91,203
0.0%
-6.3%
Intangible assets
25,070
25,508
26,570
-1.7%
-5.6%
Investments
34,667
34,814
31,484
-0.4%
+10.1%
Cash and equivalents
9,542
8,453
10,076
+12.9%
-5.3%
Receivables
40,992
39,779
39,625
+3.0%
+3.4%
Inventory
17,770
19,246
17,385
-7.7%
+2.2%
Other assets
39,455
40,260
39,242
-2.0%
+0.5%
Total assets
252,974
253,538
255,585
-0.2%
-1.0%
Questions
What was CVS Health's revenue in Q1 FY2026?
CVS Health (CVS) reported revenue of $100.4 billion for Q1 FY2026, the quarter ended 31 March 2026, up 6.2% on the same quarter a year earlier.
How much did CVS Health earn in Q1 FY2026?
Net income for Q1 FY2026 was $2.9 billion, up 65.4% on the year, and diluted earnings per share $2.30.
When did CVS Health report Q1 FY2026 results?
CVS Health filed its 10-Q for the quarter ended 31 March 2026 with the SEC on 6 May 2026.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 31 March 2026, filed 6 May 2026: the filing.